Cited by 1,200Dermatology and Skin DiseasesReliability and Agreement in MeasurementContact Dermatitis and Allergies

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., Evaluator Group, The Easi·2001·Experimental Dermatology

DOI 10.1034/j.1600-0625.2001.100102.x

Open this paper in CoChat — free account

Abstract

OBJECTIVE: To test the reliability of the eczema area and severity index (EASI) scoring system by assessing inter- and intra-observer consistency. DESIGN: Training of evaluators, application, and assessment over 2 consecutive days. SETTING: An academic center. PATIENTS: Twenty adults and children with atopic dermatitis (AD); cohort 1 (10 patients > or = 8 years) and cohort 2 (10 patients < 8 years). INTERVENTIONS: None. MAIN OUTCOME MEASURE: The EASI was used by 15 dermatologist evaluators to assess atopic dermatitis in cohort 1 and cohort 2 on 2 consecutive days. Inter- and intraobserver reliability were analyzed. RESULTS: Overall intra-evaluator reliability of the EASI was in the fair-to-good range. Inter-evaluator reliability analyses indicated that the evaluators assessed the patients consistently across both study days. CONCLUSIONS: This study demonstrated that the EASI can be learned quickly and utilized reliably in the assessment of severity and extent of AD. There was consistency among the evaluators between consecutive days of evaluation. These results support the use of the EASI in clinical trials of therapeutic agents for AD.

Integrity signals

Registry

Crossref · 10.1034/j.1600-0625.2001.100102.x

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Diagnostic features of atopic dermatitis
Hanifin, J. M., & Rajka, G. (1980) · Acta Dermato-Venereologica · doi:10.2340/00015555924447 · Cited by 5,086
Self-citation
The Design and Analysis of Clinical Experiments
Fleiss, J. L. (1999) · Wiley eBooks · doi:10.1002/9781118032923 · Cited by 4,819
Severe Psoriasis – Oral Therapy with a New Retinoid
Fredriksson, T., & Pettersson, U. (2009) · Dermatologica · doi:10.1159/000250839 · Cited by 2,718
Severity Scoring of Atopic Dermatitis: The SCORAD Index
(2009) · Dermatology · doi:10.1159/000247298 · Cited by 2,304
Large sample standard errors of kappa and weighted kappa.
Fleiss, J. L., Cohen, J., & Everitt, B. S. (1969) · Psychological Bulletin · doi:10.1037/h0028106 · Cited by 1,536
Grading of the severity of atopic dermatitis.
Rajka, G., & Langeland, T. (1989) · PubMed · doi:10.2340/000155551441314 · Cited by 415
Double-blind, controlled, crossover study of cyclosporin in adults with severe refractory atopic dermatitis
Sowden, J. M., Allen, B. R., Berth‐Jones, J., GRAHAM-BROWN, R. A. C., Motley, R., Finlay, A. Y., Salek, S., Marks, R., Ross, J., & Camp, R. D. R. (1991) · The Lancet · doi:10.1016/0140-6736(91)90134-b · Cited by 411
Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children
Kang, S., Lucky, A. W., Pariser, D. M., Lawrence, I., & Hanifin, J. M. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109812 · Cited by 329
Self-citation
A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients
Paller, A. S., Eichenfield, L. F., Leung, D. Y. M., Stewart, D., & Appell, M. L. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109813 · Cited by 323
Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: Part I, efficacy
Hanifin, J. M., LING, M. R., Langley, R. G. B., Breneman, D., & Rafal, E. S. (2001) · Journal of the American Academy of Dermatology · doi:10.1067/mjd.2001.109810 · Cited by 285
Self-citation

Show all 17 references

Research works printed but not linked: 1

Fleiss J L, 1986, New York., 1

Sorted by citations

Items 801–900 of 1,000

Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events
Bissonnette, R., Eichenfield, L. F., Simpson, E. L., Thaçi, D., Kabashima, K., Thyssen, J. P., Guttman‐Yassky, E., Nunes, F. P., Gamalo, M., Ahmad, F., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18881 · Cited by 6
Intramuscular Injection of Autologous Serum in Adolescent and Adult Patients with Atopic Dermatitis: A Preliminary Randomized Clinical Trial
Nahm, D., Kim, M., Kwon, B., Kim, J. S., & Park, B. (2023) · Yonsei Medical Journal · doi:10.3349/ymj.2022.0559 · Cited by 6
Prediction of disease severity using serum biomarkers in patients with mild-moderate Atopic Dermatitis: A pilot study
Lee, I., Yeom, M., Kim, K., Hahm, D., Kang, S.-H., & Park, H. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293332 · Cited by 6
Burden of Disease in Real-Life Setting of Patients With Atopic Dermatitis: Italian Data From the MEASURE-AD Study
Argenziano, G., Mercuri, S. R., Savoia, P., Amerio, P., Fortina, A. B., Bongiorno, M. R., Giudice, M. B. D. F. D., Parodi, A., Pimpinelli, N., Stingeni, L., et al. (2024) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1401a79 · Cited by 6
Basidiomycetes-X, an edible mushroom, alleviates the development of atopic dermatitis in NC/Nga mouse model
Watanabe, K., Karuppagounder, V., Sreedhar, R., Kandasamy, G., Harima, M., Ravichandiran, V., & Arumugam, S. (2018) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2018.10.005 · Cited by 6
Emerging systemic therapies for atopic dermatitis: oral small molecules and targeted topical agents
Nusbaum, K. B., Nguyen, C., & Fleischer, A. B. (2020) · Journal of Dermatological Treatment · doi:10.1080/09546634.2020.1837721 · Cited by 6
Establishing Consensus on the Treatment of Toxicodendron Dermatitis
Butt, M., Marks, J. G., & Flamm, A. F. (2022) · Dermatitis · doi:10.1097/der.0000000000000894 · Cited by 6
Clinical features of atopic dermatitis in pediatric patients with skin of color and comparison with different phototypes
Herzum, A., Occella, C., Gariazzo, L., Ciccarese, G., Pastorino, C., Matarese, S., Marasini, L., & Viglizzo, G. (2024) · Skin Research and Technology · doi:10.1111/srt.13614 · Cited by 6
Comparison of fumaric acid 5% cream versus triamcinolone 0.1% cream in the treatment of hand eczema.
Jowkar, F., Saki, N., Mokhtarpour, A., & Saki, M. R. (2014) · PubMed · Cited by 6
Topical Tacrolimus for the Treatment of Atopic Dermatitis with Truncal Lesion
Ko, H., Kim, W. I., Cho, S. H., Park, Y. L., Choi, E. H., Son, S. W., Lew, B., Lee, Y. W., Seo, Y., Kim, G. M., et al. (2018) · Annals of Dermatology · doi:10.5021/ad.2018.30.2.173 · Cited by 6
Efficacy and safety of topical halometasone in eczematous dermatoses in Indian population: An open label, noncomparative study
Krishnankutty, B., Jerajani, H., Kumar, A. S., Kuruvila, M., Nataraja, H., Philip, M., Pratap, D. V. S., Sumathy, T. K., Dhawan, S., & Thomas, D. (2011) · Indian Journal of Dermatology · doi:10.4103/0019-5154.91822 · Cited by 6
Impaired CD23 and CD62L expression and tissue inhibitors of metalloproteinases secretion by eosinophils in adults with atopic dermatitis
Titz, T. D. O., Orfali, R. L., de Lollo, C., dos Santos, V. G., Duarte, A. J. D. S., Sato, M. N., & Aoki, V. (2016) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.13825 · Cited by 6
The Circadian Rhythm of Itching among 241 Adults with Atopic Dermatitis: A Cross-sectional Study
Sang, X., Lu, J., Tan, L., Zeng, J., Wang, D., Guo, A., Tang, S., Zeng, Q., Liu, W., & Gao, L. (2024) · Acta Dermato Venereologica · doi:10.2340/actadv.v104.35427 · Cited by 5
Evaluation of Upadacitinib Efficacy in the Treatment of Atopic Dermatitis of Sensitive Areas
Gori, N., Galluzzo, M., Chiricozzi, A., Grieco, T., Chello, C., Russo, F., Tolino, E., Pigliacelli, F., Mazzotta, A., Talamonti, M., et al. (2025) · Dermatology · doi:10.1159/000545227 · Cited by 5
Associations between dietary patterns, gut microbiome diversity, and itch severity in preschool aged children with atopic dermatitis: A cross‐sectional study
Park, J., Lee, S. J., Yan, J., Kim, S., Kim, J., Lim, C., Kim, H., & Jung, M. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70202 · Cited by 5
Depression, Anxiety and Quality of Life in Patients with Atopic Dermatitis and Psoriasis
Arnīte, A., Bondare-Ansberga, V., Reinberga, L., Hartmane, I., & Mikažāns, I. (2026) · Medicina · doi:10.3390/medicina62010164 · Cited by 5
The clinical relevance of dupilumab serum concentration in patients with atopic dermatitis: a two-center prospective cohort study
Bosma, A. L., Gerbens, L. A. A., Khattabi, H. E., Loeff, F. C., Duckworth, M., Woolf, R., Rispens, T., Smith, C. H., & Spuls, P. I. (2023) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2193663 · Cited by 5
Pruritus and Pain Constitute the Main Negative Impact of Atopic Dermatitis® from the Patient's Perspective: A Systematic Review
Hita, J. C. A., Carrascosa, J. M., Flórez, Á., Herranz, P., Rodríguez, J., Serra‐Baldrich, E., Salvador, J. F. S., Comellas, M., Isidoro, O., & de Frutos, F. J. O. (2023) · Dermatitis · doi:10.1089/derm.2023.0163 · Cited by 5
Brief parenting intervention (Triple P) for families of children with eczema: a randomized controlled trial
Mitchell, A. E., Morawska, A., Casey, E. R., Forbes, E. J., Filus, A., Fraser, J., Rowell, D., Johnston, A., & Birch, S. (2024) · Journal of Pediatric Psychology · doi:10.1093/jpepsy/jsae023 · Cited by 5
Development of Objective Measurements of Scratching as a Proxy of Atopic Dermatitis—A Review
Au, C.-Y., Manazir, N., Kang, H., & Bhagat, A. A. S. (2025) · Sensors · doi:10.3390/s25144316 · Cited by 5
Segmentation of Eczema Skin Lesions Using U-Net
Nisar, H., Tan, Y. R., & Yeap, K. H. (2021) · IEEE-EMBS Conference on Biomedical Engineering and Sciences · doi:10.1109/iecbes48179.2021.9398739 · Cited by 5
Perception of the coronavirus pandemic by patients with atopic dermatitis – Results from the TREATgermany registry
Helmert, C., Siegels, D., Haufe, E., Abraham, S., Heratizadeh, A., Kleinheinz, A., Harder, I., Schäkel, K., Effendy, I., Wollenberg, A., et al. (2021) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14655 · Cited by 5
Evaluation of standard treatments for managing adult Japanese patients with inadequately controlled moderate‐to‐severe atopic dermatitis: Two‐year data from the ADDRESS‐J disease registry
Katoh, N., Saeki, H., Kataoka, Y., Etoh, T., Teramukai, S., Takagi, H., Fujita, H., Ardeleanu, M., Rizova, E., Arima, K., et al. (2022) · The Journal of Dermatology · doi:10.1111/1346-8138.16485 · Cited by 5
Defining the temporal relationship between the skin microbiome, immune response and skin barrier function during flare and resolution of atopic dermatitis: protocol of a Danish intervention study
Rønnstad, A. T. M., Bay, L., Ruge, I. F., Halling, A., Fritz, B. G., Jakaša, I., Luiten, R. M., Kežić, S., Thomsen, S. F., Bjarnsholt, T., et al. (2023) · BMJ Open · doi:10.1136/bmjopen-2022-068395 · Cited by 5
Antigen-specific T cell balance reveals Why patients with atopic dermatitis fail to achieve immune tolerance
Inaba, M., Fukushima, H., Hara, M., Hosaka, S., Fujiyama, S., Maruo, K., Nomura, T., Okiyama, N., & Takada, H. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109649 · Cited by 5
Psychometric evaluation of the Worst Pruritus Numerical Rating Scale (NRS), Atopic Dermatitis Symptom Scale (ADerm-SS), and Atopic Dermatitis Impact Scale (ADerm-IS)
Silverberg, J. I., Leshem, Y. A., Calimlim, B., McDonald, J., & Litcher‐Kelly, L. (2023) · Current Medical Research and Opinion · doi:10.1080/03007995.2023.2251883 · Cited by 5
Disease burden among patients with atopic dermatitis treated with systemic therapy for 4–12 months: results from the CorEvitas Atopic Dermatitis Registry
Silverberg, J. I., Pierce, E. J., Feely, M. A., Atwater, A. R., Schrader, A. M., Jones, E. A., Dave, S. S., & Simpson, E. L. (2023) · Journal of Dermatological Treatment · doi:10.1080/09546634.2023.2246601 · Cited by 5
Ethnic endotypes in paediatric atopic dermatitis depend on immunotype, lipid composition and microbiota of the skin
Andersson, A. M., Ingham, A. C., Edslev, S. M., Sølberg, J., Skov, L., Koch, A., der Vlugt, K. G., Stet, F. S., Brüggen, M., Jakaša, I., et al. (2023) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19565 · Cited by 5
Effect of a topical traditional Chinese herbal medicine on skin microbiota in mouse model of atopic dermatitis
Zeng, B., Liu, X., Zhou, Y., Cui, G., Li-li, A., & Yang, Z. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e33240 · Cited by 5
The Effect of Environmentally Friendly Wallpaper and Flooring Material on Indoor Air Quality and Atopic Dermatitis: A Pilot Study
Na, J., Byun, S. Y., Jeong, M. Y., Park, K. C., & Huh, C. (2014) · Annals of Dermatology · doi:10.5021/ad.2014.26.6.688 · Cited by 5
Emollients for eczema
Oranje, A. P., der Spek, F. B. D. W., Ordonez, C. P., Raeve, L. E. D., Spierings, M., & van der Wouden, J. C. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008304.pub2 · Cited by 5
Characterizing the microcirculation of atopic dermatitis using angiographic optical coherence tomography
Byers, R. A., Maiti, R., Danby, S. G., Pang, E. J., Mitchell, B., Carré, M., Lewis, R., Cork, M. J., & Matcher, S. J. (2017) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.2252407 · Cited by 5
Defining and Measuring the Scope of Atopic Dermatitis
Laird, M. E., & Sicco, K. L. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-64804-0_9 · Cited by 5
Antipruritic Effect of Qingpeng Ointment on the Localized Nonexudative Eczema
Li, Y., Xu, W., Li, L., & Zhang, R. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/4961691 · Cited by 5
Factors Influencing Family Burden of Paediatric Patients with Atopic Dermatitis: A Cross-sectional Study
Xu, X., van Galen, L. S., Bajpai, R. C., Koh, M. J. A., Thng, S. T. G., Yew, Y. W., Järbrink, K., & Car, J. (2020) · Acta Dermato Venereologica · doi:10.2340/00015555-3458 · Cited by 5
Prevention of Transcutaneous Sensitization to Cow Milk Proteins in Infants with Atopic Dermatitis: Cohort Study
Murashkin, N. N., Makarova, S. G., Григорьев, С. Г., Fedorov, D. V., Ivanov, R. A., Ambarchian, E. Т., Epishev, R. V., Materikin, A. I., Opryatin, L. A., & Savelova, A. A. (2020) · Вопросы современной педиатрии · doi:10.15690/vsp.v19i6.2152 · Cited by 5
Different strategies for using topical corticosteroids for established eczema
Moed, H. D., Yang, Q., Oranje, A. P., Panda, S., & van der Wouden, J. C. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010080 · Cited by 5
Retracted
A Statistical Model to Predict the Reduction of Lichenification in Atopic Dermatitis
Glazenburg, E. J., Mulder, P. G. H., & Oranje, A. P. (2015) · Acta Dermato Venereologica · doi:10.2340/00015555-1881 · Cited by 5
The Ameliorative Effect of β-sitosterol on DNCB-induced Atopic Dermatitis in Mice
Kim, S.-J. (2017) · Journal of Experimental & Biomedical Sciences/Biomedical Science Letters · doi:10.15616/bsl.2017.23.4.303 · Cited by 5
Dermatite atopique de l’adulte : présentation clinique, complications et comorbidités
Reguiaï, Z. (2017) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/s0151-9638(18)30087-5 · Cited by 5
Single nucleotide variations in genes associated with innate immunity are enriched in Japanese adult cases of face and neck type atopic dermatitis
Yasuda-Sekiguchi, F., Shiohama, A., Fukushima‐Nomura, A., Obata, S., Mochimaru, N., Honda, A., Kawasaki, H., Kubo, A., Ebihara, T., Amagai, M., et al. (2020) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2020.11.005 · Cited by 5
Paediatric atopic eczema (atopic dermatitis) in South Africa: A practical algorithm for the management of mild-to-moderate disease in daily clinical practice
Kannenberg, S. M. H., Karabus, S. J., Visser, W. I., Aboobaker, J., Kriel, M., Levin, M. E., Magigaba, B. P., Manjra, A. I., Misra, R., Mpofu, P., et al. (2020) · South African Family Practice · doi:10.4102/safp.v62i1.5190 · Cited by 5
Psychological and educational interventions for managing eczema
Singleton, H., Hodder, A., Boyers, D., Doney, L., Almilaji, O., Heaslip, V., Thompson, A. R., Boyle, R. J., Axon, E., Onselen, J. V., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014932 · Cited by 5
Topical anti-inflammatory treatments for eczema: network meta-analysis
Steele, L., Stuart, B. L., Axon, E., Lax, S. J., Harvey, J., Roberts, A., Santer, M., Williams, H. C., Drucker, A. M., & Boyle, R. J. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd015064 · Cited by 6
Safety and Activity of UR-1505 in Atopic Dermatitis: A Randomized, Double-blind Phase II Exploratory Trial
Vives, R., Pontes, C., Sarasa, M., & Millier, A. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.06.005 · Cited by 5
MALVA SYLVESTRIS IN THE TREATMENT OF HAND ECZEMA
Barikbin, B., Marefat, A., Rahgoshai, R., Moravvej, H., Mohtasham, N., & Yousefi, M. (2010) · Faṣlnāmah-i bīmārīhā-yi pūst · Cited by 5
A Phase 3, Long-Term, Open-Label Study of Difamilast Ointment to Evaluate Efficacy and Safety in Japanese Infants with Atopic Dermatitis
Saeki, H., Ohya, Y., Baba, N., Imamura, T., Yokota, D., & Tsubouchi, H. (2025) · Dermatology and Therapy · doi:10.1007/s13555-025-01581-1 · Cited by 4
Improved patient‐ and caregiver‐reported outcomes distinguish tacrolimus 0.03% from crisaborole in children with atopic dermatitis
Wolf, J. R., Chen, A., Wieser, J. K., Johnson, B., Baughman, L., Lee, G., Pope, E. M., Franco, A. I., Love, T., & Beck, L. A. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.19807 · Cited by 4
Efficacy and Safety of Omalizumab and Dupilumab in Pediatric Patients with Skin Diseases: An Observational Study
Galletta, F., Rizzuti, L., Passanisi, S., Rosa, E., Caminiti, L., & Manti, S. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15020064 · Cited by 4
Frequency and clinical features of disease flares in patients with atopic dermatitis treated with dupilumab
Trave, I., Salvi, I., Battaglia, G., Vischi, A., Parodi, A., & Cozzani, E. (2025) · Journal of Dermatological Treatment · doi:10.1080/09546634.2025.2495831 · Cited by 4
Effectiveness of Dupilumab Treatment in Patients With Type 2 Inflammation: A Real-Life Integrated Experience
Torretta, S., Piatti, G., Catalano, C., Ferrucci, S., Cavallini, M., Rivolta, F., Bellocchi, C., D’Adda, A., Battilocchi, L., Tavecchio, S., et al. (2025) · Therapeutic Advances in Allergy and Rhinology · doi:10.1177/27534030241312540 · Cited by 4
Effectiveness of Tralokinumab for Moderate-to-Severe Atopic Dermatitis Involving the Head-and-Neck Area: A Multicenter Retrospective Cohort Study
Avallone, G., Valtellini, L., Tavoletti, G., Mastorino, L., Maurelli, M., Brizzi, E. V. D., Ippoliti, E., Barei, F., Termini, D., Quaglino, P., et al. (2025) · Dermatitis · doi:10.1177/17103568251363249 · Cited by 4
Prescription and application adequacy of topical corticosteroids based on the finger‐tip unit method in adult patients with atopic dermatitis: A cross‐sectional study
Matsuki, F., Suzuki, S., Hirose, T., Suzuki, T., Yoshida, T., Ônishi, Y., & Yamamoto, R. (2025) · Journal of General and Family Medicine · doi:10.1002/jgf2.70055 · Cited by 4
Safer oral immunotherapy with very low-dose introduction for pediatric hen’s egg allergy
Ishikawa, F., Miyaji, Y., Yamamoto‐Hanada, K., Shimada, M., Kiguchi, T., Hirai, S., Kram, Y. E., Takada, K., Noguchi, K., Inuzuka, Y., et al. (2025) · Journal of Allergy and Clinical Immunology Global · doi:10.1016/j.jacig.2025.100542 · Cited by 4
Food Sensitization Is Associated With Atopic Dermatitis Severity, Gut‐Derived Metabolites and Leaky Gut in Adults
Blicharz, L., Samborowska, E., Zagożdżon, R., Czuwara, J., Zych, M., Roszczyk, A., Zaremba, M., Dadlez, M., Samochocki, Z., Olszewska, M., et al. (2025) · Clinical and Translational Allergy · doi:10.1002/clt2.70094 · Cited by 4
Cytokine levels and clinical characteristics in the tear fluid of patients with atopic dermatitis and atopic keratoconjunctivitis
Hansen, P. M., Utheim, T. P., Aass, H. C. D., Reppe, S., Hedengran, A., Hadad, R., Sjö, A. D., Thyssen, J. P., Kolko, M., & Heegaard, S. (2026) · The Ocular Surface · doi:10.1016/j.jtos.2026.02.010 · Cited by 4
Cost‐effectiveness analysis of delgocitinib in adult patients with atopic dermatitis in Japan
Takenaka, M., Matsumoto, M., Murota, H., Inoue, S., Shibahara, H., Yoshida, K., Takigawa, S., & Ishimoto, A. (2021) · Journal of Cutaneous Immunology and Allergy · doi:10.1002/cia2.12163 · Cited by 4
Single‐center survey of biologic use for inflammatory skin diseases during the coronavirus disease 2019 pandemic
Kado, S., Kamiya, K., Kishimoto, M., Maekawa, T., Kuwahara, A., Sugai, J., Komine, M., & Ohtsuki, M. (2021) · The Journal of Dermatology · doi:10.1111/1346-8138.16159 · Cited by 4
Clinical efficacy and safety of topical difamilast in the treatment of patients with atopic dermatitis: a systematic review and meta-analysis of randomized controlled trials
Lu, L., Chao, C., Chang, S.-P., Lan, S., & Lai, C. (2022) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2022.2134114 · Cited by 4
Digital Outcome Measurement to Improve Care for Patients With Immune-Mediated Inflammatory Diseases: Protocol for the IMID Registry
Looijen, A. E. M., van Linschoten, R. C. A., Brugma, J.-D. C., Hijnen, D., de Jong, P. H. P., van der Kuy, P. H. M., van Laar, J. A. M., van der Woude, C. J., & Pasma, A. (2023) · JMIR Research Protocols · doi:10.2196/43230 · Cited by 4
Establishment and Utility of SwedAD: A Nationwide Swedish Registry for Patients with Atopic Dermatitis Receiving Systemic Pharmacotherapy
Alsterholm, M., Svedbom, A., Anderson, C. D., Sommar, L. H., Ivert, L. U., Josefson, A., von Kobyletzki, L., Lindberg, M., Lundeberg, L., Lundqvist, M., et al. (2023) · Acta Dermato Venereologica · doi:10.2340/actadv.v103.7312 · Cited by 4
A Review of Atomic-Force Microscopy in Skin Barrier Function Assessment
Pereda, J., Khatib, C. M., Kežić, S., Christensen, M. O., Yang, S., Thyssen, J. P., Chu, C., Riethmüller, C., Liao, H.-S., Akhtar, I., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.04.005 · Cited by 4
Stratum corneum nanotexture feature detection using deep learning and spatial analysis: a noninvasive tool for skin barrier assessment
Wang, J., Pereda, J., Du, C.-W., Chu, C., Christensen, M. O., Kežić, S., Jakaša, I., Thyssen, J. P., Satheesh, S. K., & Hwu, E. (2024) · GigaScience · doi:10.1093/gigascience/giae095 · Cited by 4
Food hypersensitivity in adult patients with atopic dermatitis in Korea
Yang, Y.-S., Byun, Y.-S., Kim, J.-H., Kim, H. O., & Park, C. W. (2014) · Clinical and Experimental Dermatology · doi:10.1111/ced.12433 · Cited by 4
Fingolimod hydrochloride gel shows promising therapeutic effects in a mouse model of atopic dermatitis
Tamakuwala, M. A., Ratna, W. N., Joshi, A., & Stagni, G. (2016) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.12588 · Cited by 4
Modeling of Temporal Exposure to the Ambient Environment and Eczema Severity
Thomas, B., Tan, X. L., Javadzadeh, S., Robinson, E. J., McDonald, B., Krupiczojc, M. A., Rahman, S. R., Rahman, S., Ahmed, R., Begum, R., et al. (2021) · JID Innovations · doi:10.1016/j.xjidi.2021.100062 · Cited by 4
Polymorphisms of the filaggrin gene are associated with atopic dermatitis in the Caucasian population of Central Russia
Churnosov, M. I., Belyaeva, T. M., Александрович, Р. Е., Dvornyk, V., & Ponomarenko, I. (2022) · Gene · doi:10.1016/j.gene.2022.146219 · Cited by 4
Dermatitis atópica
Armario-Hita, J. C., Galán‐Gutiérrez, M., & Carrascosa, J. M. (2021) · Más dermatología · doi:10.5538/1887-5181.2021.34.5 · Cited by 4
Release of Cervical Muscle Tension Improves Psychological Stress and Symptoms of Moderate-to-Severe Atopic Dermatitis: a Case Series with 20 Patients
Hosono, S., Fujita, K., Nimura, A., & Akita, K. (2022) · Dermatology and Therapy · doi:10.1007/s13555-022-00814-x · Cited by 5
Two cases of dupilumab-associated conjunctivitis with high expression of IL-8 mRNA on the ocular surface: a case report
Adachi, R., Shoji, J., Hirota, A., Tomioka, A., Tonozuka, Y., Inada, N., & Yamagami, S. (2022) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-022-00727-6 · Cited by 4
Atopic Dermatitis and Allergic Contact Dermatitis
Leung, D. Y. M., & Boguniewicz, M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37579-5.00011-8 · Cited by 4
The Influence of Atopic Dermatitis on Health-Related Quality of Life in Bangladesh
Nagata, A., Kazi, T., Akter, Z., Nody, F. A., Khan, M. S., Shahriar, A. S. M., Islam, M. S., Nakagawa, T., & Inui, S. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph182111593 · Cited by 4
Translation and validation of Portuguese of a questionnaire for evaluation of psychosomatic symptoms in adults with atopic dermatitis
Boleira, M., Lupi, O., Pires, G. V., Dias, G. A. C., Seba, A., & Guimarães, D. B. S. (2014) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20142707 · Cited by 4
Very late antigen‐1 in psoriasis: an immunohistochemical study
Baum, S., Barzilai, A., Huszar, M., Greenberger, S., Trau, H., & Bank, I. (2007) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2007.02402.x · Cited by 4
The Therapeutic Efficacy of the Moisturizer APDDR-0801 for Patients with Atopic Dermatitis
Park, J., Lee, K. H., Kim, J., Ro, Y. S., Park, C. W., Park, W. S., Koh, H. J., Kim, J. H., & Seo, S. J. (2010) · The Royal Society of Chemistry’s Journals, Books and Databases (The Royal Society of Chemistry) · Cited by 4
Avaliação da qualidade de vida dos pacientes adultos com dermatite atópica
Coghi, S. L. (2005) · doi:10.11606/d.5.2005.tde-02092005-152844 · Cited by 4
1% Pimecrolimus Cream for Atopic Dermatitis
Eichenfield, L. F., Lucky, A. W., Boguniewicz, M., Langley, R. G. B., Cherill, R., & Marshall, K. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.10.1369 · Cited by 4
Self-citation
Clinical Assessment of Abrocitinib, Tofacitinib, and Cyclosporine in Adult Patients With Moderate to Severe Atopic Dermatitis: A Retrospective Analysis
Bashir, S. (2025) · Cureus · doi:10.7759/cureus.85448 · Cited by 3
Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice
Kui, L., Huang, J., Wang, G., Zhao, J., Wang, S., Qin, X., Liu, L., Hu, J., Chen, L., Wang, X., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1667195 · Cited by 3
Effectiveness and Safety of Dupilumab in Patients with Chronic Rhinosinusitis with Nasal Polyps and Associated T2 Comorbidities: One-Year Real Life Round
Nettis, E., Casella, R., Leo, E. D., Zaza, I., Rizzini, F. L., Vrenna, A., Brussino, L., Ridolfi, I., Bonzano, L., Ginaldi, L., et al. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041373 · Cited by 3
Rezpegaldesleukin treatment of moderate-to-severe atopic dermatitis (REZOLVE-AD): final results from the 16-week induction period of an international, double-blind, placebo-controlled, randomised phase 2b study
Silverberg, J. I., Rosmarin, D. M., Bieber, T. R. M., Chovatiya, R., Gooderham, M., Gkalpakiotis, S., Reich, A., Murrell, D. F., Skibińska, J., Sadick, N., et al. (2026) · The Lancet · doi:10.1016/s0140-6736(26)01143-8 · Cited by 3
Skin health of Aboriginal children living in urban communities
Ricciardo, B. M., Kessaris, H., Nannup, N., Tilbrook, D., Rind, N., Douglas, R., Ingrey, J., Walton, J., Michie, C., Farrant, B. M., et al. (2024) · Australasian Journal of Dermatology · doi:10.1111/ajd.14363 · Cited by 3
Unveiling the Impact of Moderate and Severe Atopic Dermatitis: Insights on Burden, Clinical Characteristics, and Healthcare Resource Utilization in Adult Greek Patients from the APOLO Cross-Sectional Study
Stratigos, A., Chasapi, V., Katoulis, A., Vakirlis, E., Psarros, F., Georgiou, S., Vourdas, D., Makris, M. P., Lazaridou, E., Gregoriou, S., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13216327 · Cited by 3
Validation of the Atopic Dermatitis Control Tool (ADCT) and a Comparison with the Recap of Atopic Eczema Questionnaire (RECAP)
Zhang, J., Miltner, L. A., Loman, L., Ragamin, A., Oosterhaven, J. A. F., & Schuttelaar, M. L. A. (2025) · Acta Dermato Venereologica · doi:10.2340/actadv.v105.42364 · Cited by 3
Emulsion containing a chitosan derivative in children with mild atopic dermatitis: A randomized controlled trial
Sagara, N., Akashi, K., Sato, M., Nagao, M., & Katsunuma, T. (2025) · Pediatric Allergy and Immunology · doi:10.1111/pai.70076 · Cited by 3
Clinical Characteristics, Diagnostic Approaches, Therapeutic Management, and Associated Comorbidities of Prurigo Nodularis (Chronic Nodular Prurigo): An Observational Study in Clinical Practice in Spain
Hita, J. C. A., Pereyra‐Rodriguez, J. J., de Frutos, F. J. O., Herranz, P., Salvador, J. F. S., Serna, M. R., Serra‐Baldrich, E., Tribó, M. J., Carrascosa, J. M., Flórez, Á., et al. (2025) · International Journal of Dermatology · doi:10.1111/ijd.17878 · Cited by 3
Patient Burden And Impact Of Moderate-to-Severe Atopic Dermatitis In the Spanish Healthcare System: The APOLO Cross-Sectional Study
de la Cueva, P., Curto‐Barredo, L., Salvador, J. F. S., Serra‐Baldrich, E., Herranz, P., Hernández‐Cano, N., de Frutos, F. J. O., Gullón, G. R., Belloso, R. M. I., Ortega, I. A., et al. (2025) · Dermatology Practical & Conceptual · doi:10.5826/dpc.1503a5538 · Cited by 3
Different strategies for using topical corticosteroids for established eczema
Moed, H. D., Yang, Q., Oranje, A. P., Panda, S., & van der Wouden, J. C. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010080.pub2 · Cited by 3
Therapeutic Potential of Atopy-camp: A pilot study
Lee, N.-R., Kim, H.-G., & Seo, K.-S. (2010) · Cited by 3
Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches
Chiricozzi, A., Peroni, D. G., & Girolomoni, G. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1516748 · Cited by 3
Dupilumab in Atopic Dermatitis
Lázaro‐Sastre, M., Garcı́a-Sánchez, A., Gómez‐Cardeñosa, A., & Davila, I. J. (2019) · Current Treatment Options in Allergy · doi:10.1007/s40521-019-00218-x · Cited by 3
Use of specific acupuncture techniques in lingering nummular eczema: A case report
Wang, J., Ma, L., Fard, M. R. A., & Mohammadi, A. (2021) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2021.03.001 · Cited by 3
Different drug forms of methylprednisolone aceponate for the treatment of patients with allergic skin diseases
Kungurov, N. V., Kokhan, M. M., Keniksfest, Y. V., STUKOVA, Y. I., KORYUKINA, Y. B., & VEDERNIKOVA, S. V. (2013) · Vestnik dermatologii i venerologii · doi:10.25208/vdv603 · Cited by 3
Effectiveness of calamine lotion as an adjunctive therapy to mometasone furoate ointment in the treatment of infant eczema: A retrospective study
Meng, Y., Fan, J.-C., & Bian, W.-N. (2022) · Medicine · doi:10.1097/md.0000000000030237 · Cited by 3
Experience with dupilumab in patients with atopic dermatitis
Glukhova, E. A., Kuvshinova, E. D., & Revyakina, V. A. (2022) · Allergology and Immunology in Pediatrics · doi:10.53529/2500-1175-2022-3-14-23 · Cited by 3
The interaction between NK cells and ILC cells and their subsets in atopic dermatitis patients with and without dupilumab therapy
Boudková, P., Čermáková, E., Krejsek, J., & Čelakovská, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112327 · Cited by 3
An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
Saeki, H., Ohya, Y., Baba, N., Imamura, T., Yokota, D., & Tsubouchi, H. (2024) · Dermatology and Therapy · doi:10.1007/s13555-024-01236-7 · Cited by 3
Proxy endpoints — bridging clinical trials and real world data
Kryukov, M., Moriarty, K. P., Villamea, M., O'Dwyer, I., Chow, O., Dormont, F., Hernandez, R., Bar‐Joseph, Z., & Rufino, B. (2024) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2024.104723 · Cited by 3
Assessment of serum levels of ischemia modified albumin and interleukin-17 in children with atopic dermatitis
Omar, S. I. A., Mohamed, N. S., Eldabah, N. A. M., & Abdalhakim, E. (2024) · Archives of Dermatological Research · doi:10.1007/s00403-024-03366-6 · Cited by 3
Outcome Measures in Psoriasis and Atopic Eczema
Duffin, K. C. (2017) · Springer eBooks · doi:10.1007/978-3-319-66884-0_2 · Cited by 3

Authors: Hanifin, J. M., Thurston, M., Omoto, M., Cherill, R., Tofte, S. J., Graeber, M., & Evaluator Group, T. E.
Affiliations: Oregon Health & Science University (US)
Novartis (Switzerland) (CH)
Shiga University of Medical Science (JP)
Corresponding author: Hanifin, J. M.
ORCID: Hanifin, J. M.
Venue: Experimental Dermatology
Publisher: Wiley
Published: 2001-02
Volume: 10
Issue: 1
Pages: 11-18
ISSN: 0906-6705 (ISSN-L)
1600-0625
DOI: 10.1034/j.1600-0625.2001.100102.x
OpenAlex: W2117359358
Cited by: 1,200
References: 17
Citations by year: 2026: 69 · 2025: 85 · 2024: 92 · 2023: 101 · 2022: 84 · 2021: 98 · 2020: 82 · 2019: 63 · 2018: 47 · 2017: 46 · 2016: 53 · 2015: 28 · 2014: 43 · 2013: 23 · 2012: 21
FWCI: 20.78
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor, 2713 d)
Locations: Experimental Dermatology (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Dermatology › Dermatology and Skin Diseases
Social Sciences › Decision Sciences › Statistics, Probability and Uncertainty › Reliability and Agreement in Measurement
Health Sciences › Medicine › Dermatology › Contact Dermatitis and Allergies
Keywords: Eczema Area and Severity Index, atopic dermatitis, inter-rater reliability, intra-rater reliability, disease severity assessment, disease extent assessment, clinical trial outcome measures
MeSH terms: Adolescent, Adult, Child, Child, Preschool, Dermatitis, Atopic, Dermatology, Eczema, Humans, Infant, Infant, Newborn, Severity of Illness Index, Reproducibility of Results, Cohort Studies, Observer Variation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks